Casticin Inhibits In Vivo Growth of Xenograft Tumors of Human Oral Cancer SCC-4 Cells

Conclusion: These findings support further investigations in the potential use of casticin as an oral anti-cancer drug in the future.

Source: In Vivo - August 30, 2020 Category: Research Authors: SHANG, H.-S., CHEN, K.-W., CHOU, J.-S., PENG, S.-F., CHEN, Y.-L., CHEN, P.-Y., HUANG, H.-C., LU, H.-F., CHANG, H.-Y., SHIH, Y.-L., HUANG, W.-W. Tags: Experimental Studies Source Type: research